<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36674665</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>06</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>COVID-19 Heart Lesions in Children: Clinical, Diagnostic and Immunological Changes.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1147</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24021147</ELocationID><Abstract><AbstractText>In the beginning of COVID-19, the proportion of confirmed cases in the pediatric population was relatively small and there was an opinion that children often had a mild or asymptomatic course of infection. Our understanding of the immune response, diagnosis and treatment of COVID-19 is highly oriented towards the adult population. At the same time, despite the fact that COVID-19 in children usually occurs in a mild form, there is an incomplete understanding of the course as an acute infection and its subsequent manifestations such as Long-COVID-19 or Post-COVID-19, PASC in the pediatric population, correlations with comorbidities and immunological changes. In mild COVID-19 in childhood, some authors explain the absence of population decreasing T and B lymphocytes. Regardless of the patient's condition, they can have the second phase, related to the exacerbation of inflammation in the heart tissue even if the viral infection was completely eliminated-post infectious myocarditis. Mechanism of myocardial dysfunction development in MIS-C are not fully understood. It is known that various immunocompetent cells, including both resident inflammatory cells of peripheral tissues (for example macrophages, dendritic cells, resident memory T-lymphocytes and so on) and also circulating in the peripheral blood immune cells play an important role in the immunopathogenesis of myocarditis. It is expected that hyperproduction of interferons and the enhanced cytokine response of T cells 1 and 2 types contribute to dysfunction of the myocardium. However, the role of Th1 in the pathogenesis of myocarditis remains highly controversial. At the same time, the clinical manifestations and mechanisms of damage, including the heart, both against the background and after COVID-19, in children differ from adults. Further studies are needed to evaluate whether transient or persistent cardiac complications are associated with long-term adverse cardiac events.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vasichkina</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7336-4102</Identifier><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alekseeva</LastName><ForeName>Daria</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>H. Turner National Medical Research Center for Children's Orthopedics and Trauma Surgery of the Ministry of Health of the Russian Federation, 196603 St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kudryavtsev</LastName><ForeName>Igor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Experimental Medicine, 197341 St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glushkova</LastName><ForeName>Anzhela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology, 192019 St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Starshinova</LastName><ForeName>Anastasia Y</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Medical Department, Saint Petersburg State Pediatric Medical University, 194100 St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malkova</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6008-1354</Identifier><AffiliationInfo><Affiliation>Faculty of Natural Sciences, Ariel University, Ariel 40700, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kudlay</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-1878-4467</Identifier><AffiliationInfo><Affiliation>Pharmacology Department, I.M. Sechenov First Moscow State Medical University, 119435 Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NRC Institute of Immunology FMBA of Russia, 115478 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Starshinova</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>075-15-2022-301</GrantID><Agency>Federal Almazov North-West Medical Research Centre</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000705967">pediatric multisystem inflammatory disease, COVID-19 related</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Post-COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">T cells</Keyword><Keyword MajorTopicYN="N">cardiovascular inflammation</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">coronavirus infection</Keyword><Keyword MajorTopicYN="N">myocarditis</Keyword><Keyword MajorTopicYN="N">pathogenesis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36674665</ArticleId><ArticleId IdType="pmc">PMC9866514</ArticleId><ArticleId IdType="doi">10.3390/ijms24021147</ArticleId><ArticleId IdType="pii">ijms24021147</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO  . Coronavirus Disease (COVID-19) Pandemic. WHO; Geneva, Switzerland: 2020.  [(accessed on 5 October 2022)].  Available online:  https://www.who.int/emergencies/diseases/novel-coronavirus-2019.</Citation></Reference><Reference><Citation>Sharma A., Balda S., Apreja M., Kataria K., Capalash N., Sharma P. COVID-19 Diagnosis: Current and Future Techniques. Int. J. Biol. Macromol. 2021;193:1835&#x2013;1844. doi: 10.1016/j.ijbiomac.2021.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2021.11.016</ArticleId><ArticleId IdType="pmc">PMC8585557</ArticleId><ArticleId IdType="pubmed">34774862</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenollar F., Bouam A., Ballouche M., Fuster L., Prudent E., Colson P., Tissot-Dupont H., Million M., Drancourt M., Raoult D., et al. Evaluation of the Panbio COVID-19 Rapid Antigen Detection Test Device for the Screening of Patients with COVID-19. J. Clin. Microbiol. 2021;59:e02589-20. doi: 10.1128/JCM.02589-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02589-20</ArticleId><ArticleId IdType="pmc">PMC8111145</ArticleId><ArticleId IdType="pubmed">33139420</ArticleId></ArticleIdList></Reference><Reference><Citation>To K.K., Sridhar S., Chiu K.H., Hung D.L., Li X., Hung I.F., Tam A.R., Chung T.W., Chan J.F., Zhang A.J., et al. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerg. Microbes. Infect. 2021;10:507&#x2013;535. doi: 10.1080/22221751.2021.1898291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1898291</ArticleId><ArticleId IdType="pmc">PMC8006950</ArticleId><ArticleId IdType="pubmed">33666147</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadj Hassine I. Covid-19 vaccines and variants of concern: A review. Rev. Med. Virol. 2022;32:e2313. doi: 10.1002/rmv.2313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2313</ArticleId><ArticleId IdType="pmc">PMC8646685</ArticleId><ArticleId IdType="pubmed">34755408</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldsmith C.S., Miller S.E., Martines R.B., Bullock H.A., Zaki S.R. Electron microscopy of SARS-CoV-2: A challenging task. Lancet. 2020;395:e99. doi: 10.1016/S0140-6736(20)31188-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31188-0</ArticleId><ArticleId IdType="pmc">PMC7237172</ArticleId><ArticleId IdType="pubmed">32442529</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra S.K., Tripathi T. One year update on the COVID-19 pandemic: Where are we now? Acta Trop. 2021;214:105778. doi: 10.1016/j.actatropica.2020.105778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.actatropica.2020.105778</ArticleId><ArticleId IdType="pmc">PMC7695590</ArticleId><ArticleId IdType="pubmed">33253656</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Rao Z. Structural biology of SARS-CoV-2 and implications for therapeutic development. Nat. Rev. Microbiol. 2021;19:685&#x2013;700. doi: 10.1038/s41579-021-00630-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00630-8</ArticleId><ArticleId IdType="pmc">PMC8447893</ArticleId><ArticleId IdType="pubmed">34535791</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J.Y., Smith D.M. SARS-CoV-2 Variants of Concern. Yonsei Med. J. 2021;62:961&#x2013;968. doi: 10.3349/ymj.2021.62.11.961.</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2021.62.11.961</ArticleId><ArticleId IdType="pmc">PMC8542474</ArticleId><ArticleId IdType="pubmed">34672129</ArticleId></ArticleIdList></Reference><Reference><Citation>Amer H.M. Bovine-like coronaviruses in domestic and wild ruminants. Anim. Health Res. Rev. 2018;19:113&#x2013;124. doi: 10.1017/S1466252318000117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1466252318000117</ArticleId><ArticleId IdType="pmc">PMC7108644</ArticleId><ArticleId IdType="pubmed">30683171</ArticleId></ArticleIdList></Reference><Reference><Citation>Starshinova A.A., Kushnareva E.A., Malkova A.M., Dovgalyuk I.F., Kudlay D.A. New coronavirus infection: Features of the clinical course, the possibilities of diagnosis, treatment and prevention of infection in adults and children. Quest. Mod. Pediatr. 2020;19:42&#x2013;50. (In Russian)</Citation></Reference><Reference><Citation>Papanikolaou V., Chrysovergis A., Ragos V., Tsiambas E., Katsinis S., Manoli A., Papouliakos S., Roukas D., Mastronikolis S., Peschos D., et al. From delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants. Gene. 2022;814:146134. doi: 10.1016/j.gene.2021.146134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2021.146134</ArticleId><ArticleId IdType="pmc">PMC8725615</ArticleId><ArticleId IdType="pubmed">34990799</ArticleId></ArticleIdList></Reference><Reference><Citation>SARS-CoV-2 Variant Classifications and Definitions. Centers for Disease Control and Prevention.  [(accessed on 22 December 2021)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classifications.html.</Citation></Reference><Reference><Citation>World Health Organization  Weekly Epidemiological Update on COVID-19&#x2014;31 August 2021.  [(accessed on 10 September 2021)]; Available online:  https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19&#x2014;31-august-2021.</Citation></Reference><Reference><Citation>Aleem A., Akbar Samad A.B., Slenker A.K. Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19) StatPearls Publishing; Treasure Island, FL, USA: 2022. PMID: 34033342.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Blargan L.A., Errico J.M., Halfmann P.J., Zost S.J., Crowe J.E., Purcell L.A., Kawaoka Y., Corti D., Fremont D.H., Diamond M.S. An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies. Nat. Med. 2022;28:490&#x2013;495. doi: 10.1038/s41591-021-01678-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01678-y</ArticleId><ArticleId IdType="pmc">PMC8767531</ArticleId><ArticleId IdType="pubmed">35046573</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao K., Tzou P.L., Nouhin J., Gupta R.K., de Oliveira T., Kosakovsky Pond S.L., Fera D., Shafer R.W. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat. Rev. Genet. 2021;22:757&#x2013;773. doi: 10.1038/s41576-021-00408-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-021-00408-x</ArticleId><ArticleId IdType="pmc">PMC8447121</ArticleId><ArticleId IdType="pubmed">34535792</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-G&#xf3;mez H.R., Morf&#xed;n-Otero R., Gonz&#xe1;lez-D&#xed;az E., Esparza-Ahumada S., Le&#xf3;n-Garnica G., Rodr&#xed;guez-Noriega E. The Multifaceted Manifestations of Multisystem Inflammatory Syndrome during the SARS-CoV-2 Pandemic. Pathogens. 2022;11:556. doi: 10.3390/pathogens11050556.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11050556</ArticleId><ArticleId IdType="pmc">PMC9143280</ArticleId><ArticleId IdType="pubmed">35631077</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi D.S., Whitaker M., Marks K.J., Anglin O., Milucky J., Patel K., Pham H., Chai S.J., Kawasaki B., Meek J., et al. Hospitalizations of Children Aged 5-11 Years with Laboratory-Confirmed COVID-19&#x2014;COVID-NET, 14 States, March 2020&#x2013;February 2022. Morb. Mortal. Wkly. Rep. 2022;71:574&#x2013;581. doi: 10.15585/mmwr.mm7116e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7116e1</ArticleId><ArticleId IdType="pmc">PMC9042359</ArticleId><ArticleId IdType="pubmed">35446827</ArticleId></ArticleIdList></Reference><Reference><Citation>Noval Rivas M., Porritt R.A., Cheng M.H., Bahar I., Arditi M. Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis. Front. Immunol. 2022;13:941009. doi: 10.3389/fimmu.2022.941009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.941009</ArticleId><ArticleId IdType="pmc">PMC9300823</ArticleId><ArticleId IdType="pubmed">35874696</ArticleId></ArticleIdList></Reference><Reference><Citation>Viner R.M., Ward J.L., Hudson L.D., Ashe M., Patel S.V., Hargreaves D., Whittaker E. Systematic review of reviews of symptoms and signs of COVID-19 in children and adolescents. Arch. Dis. Child. 2020;106:802&#x2013;807. doi: 10.1136/archdischild-2020-320972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2020-320972</ArticleId><ArticleId IdType="pubmed">33334728</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Host Genetics Initiative Mapping the human genetic architecture of COVID-19. Nature. 2021;600:472&#x2013;477. doi: 10.1038/s41586-021-03767-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03767-x</ArticleId><ArticleId IdType="pmc">PMC8674144</ArticleId><ArticleId IdType="pubmed">34237774</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolopoulou G.B., Maltezou H.C. COVID-19 in Children: Where do we Stand? Arch. Med. Res. 2022;53:1&#x2013;8. doi: 10.1016/j.arcmed.2021.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2021.07.002</ArticleId><ArticleId IdType="pmc">PMC8257427</ArticleId><ArticleId IdType="pubmed">34311990</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladhani S.N., Amin-Chowdhury Z., Davies H.G., Aiano F., Hayden I., Lacy J., Sinnathamby M., De Lusignan S., Demirjian A., Whittaker H., et al. COVID-19 in children: Analysis of the first pandemic peak in England. Arch. Dis. Child. 2020;105:1180&#x2013;1185. doi: 10.1136/archdischild-2020-320042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2020-320042</ArticleId><ArticleId IdType="pmc">PMC7431771</ArticleId><ArticleId IdType="pubmed">32796006</ArticleId></ArticleIdList></Reference><Reference><Citation>Parri N., Lenge M., Buonsenso D. Children with COVID-19 in pediatric emergency departments in Italy. N. Engl. J. Med. 2020;383:187&#x2013;190. doi: 10.1056/NEJMc2007617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2007617</ArticleId><ArticleId IdType="pmc">PMC7206930</ArticleId><ArticleId IdType="pubmed">32356945</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Ermolaeva Y.U.A., Samoilova Y.U.G., Oleinik O.A., Yun E., Kudlay D.A. COVID-19 in children: Generalization of world experience. Pediatr. G. N. Speransky. 2022;101:80&#x2013;87. doi: 10.24110/0031-403X-2022-101-4-80-87. (In Russian)</Citation><ArticleIdList><ArticleId IdType="doi">10.24110/0031-403X-2022-101-4-80-87</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Zhang Q.I., Chen J., Xiang R., Song H., Shu S., Chen L., Liang L., Zhou J., You L., et al. Detection of COVID-19 in Children in Early January 2020 in Wuhan, China. N. Engl. J. Med. 2020;382:1370&#x2013;1371. doi: 10.1056/NEJMc2003717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2003717</ArticleId><ArticleId IdType="pmc">PMC7121643</ArticleId><ArticleId IdType="pubmed">32163697</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson J.F. Systematic review of COVID-19 in children show milder cases and a better prognosis than adults. Acta Paediatr. 2020;109:1088&#x2013;1095. doi: 10.1111/apa.15270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15270</ArticleId><ArticleId IdType="pmc">PMC7228328</ArticleId><ArticleId IdType="pubmed">32202343</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard-Jones A.R., Burgner D.P., Crawford N.W., Goeman E., Gray P.E., Hsu P., Kuek S., McMullan B.J., Tosif S., Wurzel D., et al. COVID-19 in children. II: Pathogenesis, disease spectrum and management. J. Paediatr. Child. Health. 2022;58:46&#x2013;53. doi: 10.1111/jpc.15811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.15811</ArticleId><ArticleId IdType="pmc">PMC8662268</ArticleId><ArticleId IdType="pubmed">34694037</ArticleId></ArticleIdList></Reference><Reference><Citation>Belhadjer Z., Meot M., Bajolle F., Khraiche D., Legendre A., Abakka S., Auriau J., Grimaud M., Oualha M., Beghetti M., et al. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation. 2020;142:429&#x2013;436. doi: 10.1161/CIRCULATIONAHA.120.048360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.048360</ArticleId><ArticleId IdType="pubmed">32418446</ArticleId></ArticleIdList></Reference><Reference><Citation>Blondiaux E., Parisot P., Redheuil A., Tzaroukian L., Levy Y., Sileo C., Schnuriger A., Lorrot M., Guedj R., Ducou le Pointe H. Cardiac MRI of children with multisystem inflammatory syndrome (MIS-C) associated with COVID-19: Case series. Radiology. 2020;297:E283&#x2013;E288. doi: 10.1148/radiol.2020202288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020202288</ArticleId><ArticleId IdType="pmc">PMC7294821</ArticleId><ArticleId IdType="pubmed">32515676</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel T., Kelleman M., West Z., Peter A., Dove M., Butto A., Oster M.E. Comparison of Multisystem Inflammatory Syndrome in Children-Related Myocarditis, Classic Viral Myocarditis, and COVID-19 Vaccine-Related Myocarditis in Children. J. Am. Heart Assoc. 2022;11:e024393. doi: 10.1161/JAHA.121.024393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.024393</ArticleId><ArticleId IdType="pmc">PMC9238597</ArticleId><ArticleId IdType="pubmed">35475362</ArticleId></ArticleIdList></Reference><Reference><Citation>Irfan O., Muttalib F., Tang K., Jiang L., Lassi Z.S., Bhutta Z. Clinical characteristics, treatment and outcomes of paediatric COVID-19: A systematic review and meta-analysis. Arch. Dis. Child. 2021;106:440&#x2013;448. doi: 10.1136/archdischild-2020-321385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2020-321385</ArticleId><ArticleId IdType="pmc">PMC8070630</ArticleId><ArticleId IdType="pubmed">33593743</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolinger M.T., Person H., Smith R., Jarchin L., Pittman N., Dubinsky M.C., Lai J. Pediatric Crohn Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated With Infliximab. J. Pediatr. Gastroenterol. Nutr. 2020;71:153&#x2013;155. doi: 10.1097/MPG.0000000000002809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPG.0000000000002809</ArticleId><ArticleId IdType="pmc">PMC7268863</ArticleId><ArticleId IdType="pubmed">32452979</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S., Principi N. Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2. Paediatr. Drugs. 2021;23:119&#x2013;129. doi: 10.1007/s40272-020-00435-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40272-020-00435-x</ArticleId><ArticleId IdType="pmc">PMC7819738</ArticleId><ArticleId IdType="pubmed">33479801</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperotto F., Friedman K.G., Son M.B.F., VanderPluym C.J., Newburger J.W., Dionne A. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: A comprehensive review and proposed clinical approach. Eur. J. Pediatr. 2021;180:307&#x2013;322. doi: 10.1007/s00431-020-03766-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-020-03766-6</ArticleId><ArticleId IdType="pmc">PMC7429125</ArticleId><ArticleId IdType="pubmed">32803422</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurray J.C., May J.W., Cunningham M.W., Jones O.Y. Multisystem inflammatory syndrome in children (MIS-C), a post-viral myocarditis and systemic vasculitis-a critical review of its pathogenesis and treatment. Front. Pediatr. 2020;8:626182. doi: 10.3389/fped.2020.626182.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.626182</ArticleId><ArticleId IdType="pmc">PMC7793714</ArticleId><ArticleId IdType="pubmed">33425823</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufort E.M., Koumans E.H., Chow E.J., Rosenthal E.M., Muse A., Rowlands J., Barranco M.A., Maxted A.M., Rosenberg E.S., Easton D., et al. Centers for Disease C and Prevention Multisystem Inflammatory Syndrome in Children Investigation, T. Multisystem inflammatory syndrome in children in New York State. N. Engl. J. Med. 2020;383:347&#x2013;358. doi: 10.1056/NEJMoa2021756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021756</ArticleId><ArticleId IdType="pmc">PMC7346766</ArticleId><ArticleId IdType="pubmed">32598830</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker E., Bamford A., Kenny J., Kaforou M., Jones C.E., Shah P., Ramnarayan P., Fraisse A., Miller O., Davies P., et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324:259. doi: 10.1001/jama.2020.10369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.10369</ArticleId><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccinelli E., Bautista-Rodriguez C., Herberg J., Kang H., Krupickova S., Altamar I.B., Moscatelli S., Sabatino J., Josen M., Paredes J., et al. Segmental and global longitudinal strain differences between Kawasaki disease and multi-system inflammatory syndrome in children. Cardiol. Young. 2022;3:1&#x2013;7. doi: 10.1017/S1047951122002414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1047951122002414</ArticleId><ArticleId IdType="pubmed">35919031</ArticleId></ArticleIdList></Reference><Reference><Citation>Benvenuto S., Simonini G., Della Paolera S., Abu Rumeileh S., Mastrolia M.V., Manerba A., Chicco D., Belgrano M., Caiffa T., Cattalini M., et al. Cardiac MRI in midterm follow-up of MISC: A multicenter study. Eur. J. Pediatr. 2022;9:1&#x2013;10. doi: 10.1007/s00431-022-04748-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04748-6</ArticleId><ArticleId IdType="pmc">PMC9734924</ArticleId><ArticleId IdType="pubmed">36484863</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatino J., Ferrero P., Chessa M., Bianco F., Ciliberti P., Secinaro A., Oreto L., Avesani M., Bucciarelli V., Calcaterra G., et al. COVID-19 and Congenital Heart Disease: Results from a Nationwide Survey. J. Clin. Med. 2020;9:1774. doi: 10.3390/jcm9061774.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9061774</ArticleId><ArticleId IdType="pmc">PMC7355526</ArticleId><ArticleId IdType="pubmed">32521643</ArticleId></ArticleIdList></Reference><Reference><Citation>Riphagen S., Gomez X., Gonzalez-Martinez C., Wilkinson N., Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607&#x2013;1608. doi: 10.1016/S0140-6736(20)31094-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31094-1</ArticleId><ArticleId IdType="pmc">PMC7204765</ArticleId><ArticleId IdType="pubmed">32386565</ArticleId></ArticleIdList></Reference><Reference><Citation>Waltuch T., Gill P., Zinns L.E., Whitney R., Tokarski J., Tsung J.W., Sanders J.E. Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department. Am. J. Emerg. Med. 2020;38:2246-e3. doi: 10.1016/j.ajem.2020.05.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.05.058</ArticleId><ArticleId IdType="pmc">PMC7255141</ArticleId><ArticleId IdType="pubmed">32471782</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung E.W., Zachariah P., Gorelik M., Boneparth A., Kernie S.G., Orange J.S., Milner J.D. Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York city. JAMA. 2020;324:294&#x2013;296. doi: 10.1001/jama.2020.10374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.10374</ArticleId><ArticleId IdType="pmc">PMC7281352</ArticleId><ArticleId IdType="pubmed">32511676</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein L.R., Rose E.B., Horwitz S.M., Collins J.P., Newhams M.M., Son M.B.F., Newburger J.W., Kleinman L.C., Heidemann S.M., Martin A.A., et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N. Engl. J. Med. 2020;383:334&#x2013;346. doi: 10.1056/NEJMoa2021680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021680</ArticleId><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrofanova L.B., Makarov I.A., Runov A.L., Vonsky M.S., Danilova I.A., Sidorin V.S., Moiseva O.M., Konradi A.O. Kliniko -morphological and molecular biological study of the myocardium in patients with COVID-19. Russ. J. Cardiol. 2022;27:4810. doi: 10.15829/1560-4071-2022-4810.</Citation><ArticleIdList><ArticleId IdType="doi">10.15829/1560-4071-2022-4810</ArticleId></ArticleIdList></Reference><Reference><Citation>Norderfeldt J., Liliequist A., Eksborg S., Frostell C., Eriksson M.J., Adding C., Agvald P., L&#xf6;nnqvist P.A. Severe Covid-19 and acute pulmonary hypertension: 24-month follow-up regarding mortality and relationship to initial echocardiographic findings and biomarkers. Acta Anaesthesiol. Scand. 2022:1&#x2013;7. doi: 10.1111/aas.14168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.14168</ArticleId><ArticleId IdType="pmc">PMC9877760</ArticleId><ArticleId IdType="pubmed">36333823</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Gonzalez M., Castellano-Martinez A., Cascales-Poyatos H.M., Perez-Reviriego A.A. Cardiovascular impact of COVID-19 with a focus on children: A systematic review. World J. Clin. Cases. 2020;8:5250&#x2013;5283. doi: 10.12998/wjcc.v8.i21.5250.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v8.i21.5250</ArticleId><ArticleId IdType="pmc">PMC7674714</ArticleId><ArticleId IdType="pubmed">33269260</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho J.S., Sia C.H., Chan M.Y., Lin W., Wong R.C. Coronavirus-induced myocarditis: A meta-summary of cases. Heart Lung. 2020;49:681&#x2013;685. doi: 10.1016/j.hrtlng.2020.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrtlng.2020.08.013</ArticleId><ArticleId IdType="pmc">PMC7440036</ArticleId><ArticleId IdType="pubmed">32861884</ArticleId></ArticleIdList></Reference><Reference><Citation>Capone C.A., Subramony A., Sweberg T., Schneider J., Shah S., Rubin L., Schleien C., Epstein S., Johnson J.C., Kessel A., et al. Characteristics, cardiac involvement, and outcomes of multisystem inflammatory disease of childhood (MIS-C) associated with SARS-CoV-2 infection. J. Pediatr. 2020;224:141&#x2013;145. doi: 10.1016/j.jpeds.2020.06.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2020.06.044</ArticleId><ArticleId IdType="pmc">PMC7293762</ArticleId><ArticleId IdType="pubmed">32553873</ArticleId></ArticleIdList></Reference><Reference><Citation>Balykova L., Vladimirov D., Krasnopolskaya A., Soldatov O., Ivyanskaya N., Shchyokina N. The defeat of the cardiovascular system with COVID-19 in children. Pediatr. G. N. Speransky. 2021;100:90&#x2013;98.</Citation></Reference><Reference><Citation>Lamers M.M., Beumer J., van der Vaart J., Knoops K., Puschhof J., Breugem T.I., Ravelli R.B.G. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020;369:50&#x2013;54. doi: 10.1126/science.abc1669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc1669</ArticleId><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Belozerov K.E., Kupreeva A.D., Avrusin I.S., Masalova V.V., Kornishina T.L., Isupova E.A., Snegireva L., Kalashnikova O., Malekov D., Pozdnyakov A., et al. Heart involvement in patients with multisystem inflammatory syndrome associated with SARS-CoV-2: A description of a series of clinical observations. Pediatr. G. N. Speransky. 2021;100:35&#x2013;45.</Citation></Reference><Reference><Citation>Radia T., Williams N., Agrawal P., Harman K., Weale J., Cook J., Gupta A. Multi-system inflammatory syndrome in children &amp; adolescents (MIS-C): A systematic review of clinical features and presentation. Paediatr. Respir. Rev. 2021;38:51&#x2013;57. doi: 10.1016/j.prrv.2020.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prrv.2020.08.001</ArticleId><ArticleId IdType="pmc">PMC7417920</ArticleId><ArticleId IdType="pubmed">32891582</ArticleId></ArticleIdList></Reference><Reference><Citation>Fainardi V., Meoli A., Chiopris G., Motta M., Skenderaj K., Grandinetti R., Bergomi A., Antodaro F., Zona S., Esposito S. Long COVID in Children and Adolescents. Life. 2022;12:285. doi: 10.3390/life12020285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12020285</ArticleId><ArticleId IdType="pmc">PMC8876679</ArticleId><ArticleId IdType="pubmed">35207572</ArticleId></ArticleIdList></Reference><Reference><Citation>Center for Disease Control and Prevention  Multisystem inflammatory syndrome in children (MIS-C) 2021.  [(accessed on 18 March 2022)]; Available online:  https://www.cdc.gov/mis-c/cases.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention  MIS-C and COVID-19.  [(accessed on 15 January 2022)]; Available online:  https://www.cdc.gov/mis-c/</Citation></Reference><Reference><Citation>Esposito S., Principi N., Azzari Ch Cardinale F., Mauro D.G., Galli L., Gattinara C.G., Fainardi V., Guarino A., Lancella L., Licari A., et al. Italian intersociety consensus on management of long covid in children. Ital. J. Pediatr. 2022;48:42. doi: 10.1186/s13052-022-01233-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-022-01233-6</ArticleId><ArticleId IdType="pmc">PMC8905554</ArticleId><ArticleId IdType="pubmed">35264214</ArticleId></ArticleIdList></Reference><Reference><Citation>Hejazi O.I., Loke Y.H., Harahsheh A.S. Short-term Cardiovascular Complications of Multi-system Inflammatory Syndrome in Children (MIS-C) in Adolescents and Children. Curr. Pediatr. Rep. 2021;9:93&#x2013;103. doi: 10.1007/s40124-021-00258-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40124-021-00258-5</ArticleId><ArticleId IdType="pmc">PMC8531914</ArticleId><ArticleId IdType="pubmed">34703656</ArticleId></ArticleIdList></Reference><Reference><Citation>Phung N.N., Thuc T., Nguyen H.T., Nguyen T.H., Nguyen T.M.T. Cardiovascular injury and clinical features of multisystem inflammatory syndrome in children (MIS-C) related to Covid-19 in Vietnam. Pediatr. Neonatol. 2022;63:569e&#x2013;574e. doi: 10.1016/j.pedneo.2022.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pedneo.2022.05.009</ArticleId><ArticleId IdType="pmc">PMC9262642</ArticleId><ArticleId IdType="pubmed">35871994</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin S.E., Bhavsar S.M., Corson A., Ghersin Z.J., Kim H.S. Cardiac Complications Associated with COVID-19, MIS-C, and mRNA COVID-19 Vaccination. Pediatr. Cardiol. 2022;43:483&#x2013;488. doi: 10.1007/s00246-022-02851-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-022-02851-x</ArticleId><ArticleId IdType="pmc">PMC8902276</ArticleId><ArticleId IdType="pubmed">35258639</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuhara J., Watanabe K., Takagi H., Sumitomo N., Kuno T. COVID-19 and multisystem inflammatory syndrome in children: A systematic review and meta-analysis. Pediatr. Pulmonol. 2021;56:837&#x2013;848. doi: 10.1002/ppul.25245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25245</ArticleId><ArticleId IdType="pmc">PMC8013394</ArticleId><ArticleId IdType="pubmed">33428826</ArticleId></ArticleIdList></Reference><Reference><Citation>Son M.B.F., Murray N., Friedman K., Young C.C., Newhams M.M., Feldstein L.R., Loftis L.L., Tarquinio K.M., Singh A.R., Heidemann S.M., et al. Overcoming COVID-19 Investigators. Multisystem Inflammatory Syndrome in Children&#x2014;Initial Therapy and Outcomes. N. Engl. J. Med. 2021;385:23&#x2013;34. doi: 10.1056/NEJMoa2102605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2102605</ArticleId><ArticleId IdType="pmc">PMC8220972</ArticleId><ArticleId IdType="pubmed">34133855</ArticleId></ArticleIdList></Reference><Reference><Citation>Theocharis P., Wong J., Pushparajah K., Mathur S.K., Simpson J.M., Pascall E., Cleary A., Stewart K., Adhvaryu K., Savis A., et al. Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19. Eur. Heart J. Cardiovasc. Imaging. 2021;22:896&#x2013;903. doi: 10.1093/ehjci/jeaa212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeaa212</ArticleId><ArticleId IdType="pmc">PMC7454452</ArticleId><ArticleId IdType="pubmed">32766671</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma C., Ganigara M., Galeotti C., Burns J., Berganza F.M., Hayes D.A., Singh-Grewal D., Bharath S., Sajjan S., Bayry J. Multisystem inflammatory syndrome in children and Kawasaki disease: A critical comparison. Nat. Rev. Rheumatol. 2021;17:731&#x2013;748. doi: 10.1038/s41584-021-00709-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00709-9</ArticleId><ArticleId IdType="pmc">PMC8554518</ArticleId><ArticleId IdType="pubmed">34716418</ArticleId></ArticleIdList></Reference><Reference><Citation>Das B.B., Akam-Venkata J., Abdulkarim M., Hussain T. Parametric Mapping Cardiac Magnetic Resonance Imaging for the Diagnosis of Myocarditis in Children in the Era of COVID-19 and MIS-C. Children. 2022;9:1061. doi: 10.3390/children9071061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children9071061</ArticleId><ArticleId IdType="pmc">PMC9320921</ArticleId><ArticleId IdType="pubmed">35884045</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Zhou Y., Wang D.W. SARS-CoV-2: A potential novel etiology of fulminant myocarditis. Herz. 2020;45:230&#x2013;232. doi: 10.1007/s00059-020-04909-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00059-020-04909-z</ArticleId><ArticleId IdType="pmc">PMC7080076</ArticleId><ArticleId IdType="pubmed">32140732</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S., Tanaka T., Inoue H., Ono C., Hashimoto S., Kioi Y., Matsumoto H., Matsuura H., Matsubara T., Shimizu K., et al. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome. Proc. Natl. Acad. Sci. USA. 2020;117:22351&#x2013;22356. doi: 10.1073/pnas.2010229117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2010229117</ArticleId><ArticleId IdType="pmc">PMC7486751</ArticleId><ArticleId IdType="pubmed">32826331</ArticleId></ArticleIdList></Reference><Reference><Citation>Blumfield E., Levin T.L. COVID-19 in pediatric patients: A case series from the Bronx, NY. Pediatr. Radiol. 2020;50:1369&#x2013;1374. doi: 10.1007/s00247-020-04782-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00247-020-04782-2</ArticleId><ArticleId IdType="pmc">PMC7388116</ArticleId><ArticleId IdType="pubmed">32728901</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracamonte-Baran W., &#x10c;ih&#xe1;kov&#xe1; D. Cardiac Autoimmunity: Myocarditis. Adv. Exp. Med. Biol. 2017;1003:187&#x2013;221. doi: 10.1007/978-3-319-57613-8_10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-57613-8_10</ArticleId><ArticleId IdType="pmc">PMC5706653</ArticleId><ArticleId IdType="pubmed">28667560</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozlov V.A., Tikhonova E.P., Savchenko A.A., Kudryavtsev I.V., Andronova N.V., Anisimova E.N., Golovkin A.S., Demina D.V., Zdzitovetsky D.E., Kalinina Y.U.S., et al. Clinical immunology. A practical guide for infectious disease specialists. Krasn. Polikor. 2021:563p. doi: 10.17513/np.518.</Citation><ArticleIdList><ArticleId IdType="doi">10.17513/np.518</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L., Fu Z. Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy. J. Immunol. Res. 2018;2018:5301548. doi: 10.1155/2018/5301548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/5301548</ArticleId><ArticleId IdType="pmc">PMC5964556</ArticleId><ArticleId IdType="pubmed">29854842</ArticleId></ArticleIdList></Reference><Reference><Citation>Annunziato F., Romagnani C., Romagnani S. The 3 major types of innate and adaptive cell-mediated effector immunity. J. Allergy. Clin. Immunol. 2015;135:626&#x2013;635. doi: 10.1016/j.jaci.2014.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2014.11.001</ArticleId><ArticleId IdType="pubmed">25528359</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudlay D., Kofiadi I., Khaitov M. Peculiarities of the T Cell Immune Response in COVID-19. Vaccines. 2022;10:242. doi: 10.3390/vaccines10020242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10020242</ArticleId><ArticleId IdType="pmc">PMC8877307</ArticleId><ArticleId IdType="pubmed">35214700</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X., Zhu J. CD4 T Helper Cell Subsets and Related Human Immunological Disorders. Int. J. Mol. Sci. 2020;21:8011. doi: 10.3390/ijms21218011.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21218011</ArticleId><ArticleId IdType="pmc">PMC7663252</ArticleId><ArticleId IdType="pubmed">33126494</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Wu D., Guo W., Cao Y., Huang D., Wang H., Wang T., Zhang X., Chen H., Yu H., et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 2020;130:2620&#x2013;2629. doi: 10.1172/JCI137244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI137244</ArticleId><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattler A., Angermair S., Stockmann H., Heim K.M., Khadzhynov D., Treskatsch S., Halleck F., Kreis M.E., Kotsch K. SARS-CoV-2-specific T cell responses and correlations with COVID-19 patient predisposition. J. Clin. Invest. 2020;130:6477&#x2013;6489. doi: 10.1172/JCI140965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140965</ArticleId><ArticleId IdType="pmc">PMC7685725</ArticleId><ArticleId IdType="pubmed">32833687</ArticleId></ArticleIdList></Reference><Reference><Citation>Afanasyeva M., Wang Y., Kaya Z., Stafford E.A., Dohmen K.M., Sadighi Akha A.A., Rose N.R. Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation. 2001;104:3145&#x2013;3151. doi: 10.1161/hc5001.100629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hc5001.100629</ArticleId><ArticleId IdType="pubmed">11748115</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D., Frisancho-Kiss S., Njoku D.B., Nyland J.F., Kaya Z., Yusung S.A., Davis S.E., Frisancho J.A., Barrett M.A., Rose N.R. Complement receptor 1 and 2 deficiency increases coxsackievirus B3-induced myocarditis, dilated cardiomyopathy, and heart failure by increasing macrophages, IL-1beta, and immune complex deposition in the heart. J. Immunol. 2006;176:3516&#x2013;3524. doi: 10.4049/jimmunol.176.6.3516.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.176.6.3516</ArticleId><ArticleId IdType="pubmed">16517720</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonderegger I., R&#xf6;hn T.A., Kurrer M.O., Iezzi G., Zou Y., Kastelein R.A., Bachmann M.F., Kopf M. Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis. Eur. J. Immunol. 2006;36:2849&#x2013;2856. doi: 10.1002/eji.200636484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200636484</ArticleId><ArticleId IdType="pubmed">17039570</ArticleId></ArticleIdList></Reference><Reference><Citation>Santa Cruz A., Mendes-Frias A., Oliveira A.I., Dias L., Matos A.R., Carvalho A., Capela C., Pedrosa J., Castro A.G., Silvestre R. Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia. Front. Immunol. 2021;12:613422. doi: 10.3389/fimmu.2021.613422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.613422</ArticleId><ArticleId IdType="pmc">PMC7930905</ArticleId><ArticleId IdType="pubmed">33679753</ArticleId></ArticleIdList></Reference><Reference><Citation>Costela-Ruiz V.J., Illescas-Montes R., Puerta-Puerta J.M., Ruiz C., Melguizo-Rodr&#xed;guez L. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62&#x2013;75. doi: 10.1016/j.cytogfr.2020.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.06.001</ArticleId><ArticleId IdType="pmc">PMC7265853</ArticleId><ArticleId IdType="pubmed">32513566</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalinina O., Golovkin A., Zaikova E., Aquino A., Bezrukikh V., Melnik O., Vasilieva E., Karonova T., Kudryavtsev I., Shlyakhto E. Cytokine Storm Signature in Patients with Moderate and Severe COVID-19. Int. J. Mol. Sci. 2022;23:8879. doi: 10.3390/ijms23168879.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23168879</ArticleId><ArticleId IdType="pmc">PMC9408700</ArticleId><ArticleId IdType="pubmed">36012146</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibabaw T. Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy. J. Inflamm. Res. 2020;13:673&#x2013;680. doi: 10.2147/JIR.S278335.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S278335</ArticleId><ArticleId IdType="pmc">PMC7547786</ArticleId><ArticleId IdType="pubmed">33116747</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcorn J.F. IL-22 Plays a Critical Role in Maintaining Epithelial Integrity During Pulmonary Infection. Front Immunol. 2020;11:1160. doi: 10.3389/fimmu.2020.01160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01160</ArticleId><ArticleId IdType="pmc">PMC7296169</ArticleId><ArticleId IdType="pubmed">32582219</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalfaoglu B., Almeida-Santos J., Tye C.A., Satou Y., Ono M. T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis. Front Immunol. 2020;11:589380. doi: 10.3389/fimmu.2020.589380.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.589380</ArticleId><ArticleId IdType="pmc">PMC7596772</ArticleId><ArticleId IdType="pubmed">33178221</ArticleId></ArticleIdList></Reference><Reference><Citation>Golovkin A., Kalinina O., Bezrukikh V., Aquino A., Zaikova E., Karonova T., Melnik O., Vasilieva E., Kudryavtsev I. Imbalanced Immune Response of T-Cell and B-Cell Subsets in Patients with Moderate and Severe COVID-19. Viruses. 2021;13:1966. doi: 10.3390/v13101966.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13101966</ArticleId><ArticleId IdType="pmc">PMC8538447</ArticleId><ArticleId IdType="pubmed">34696395</ArticleId></ArticleIdList></Reference><Reference><Citation>Assimakopoulos S.F., Eleftheriotis G., Lagadinou M., Karamouzos V., Dousdampanis P., Siakallis G., Marangos M. SARS CoV-2-Induced Viral Sepsis: The Role of Gut Barrier Dysfunction. Microorganisms. 2022;10:1050. doi: 10.3390/microorganisms10051050.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10051050</ArticleId><ArticleId IdType="pmc">PMC9143860</ArticleId><ArticleId IdType="pubmed">35630492</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudryavtsev I., Rubinstein A., Golovkin A., Kalinina O., Vasilyev K., Rudenko L., Isakova-Sivak I. Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview. Viruses. 2022;14:1082. doi: 10.3390/v14051082.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14051082</ArticleId><ArticleId IdType="pmc">PMC9147674</ArticleId><ArticleId IdType="pubmed">35632823</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldeviano G.C., Barin J.G., Talor M.V., Srinivasan S., Bedja D., Zheng D., Gabrielson K., Iwakura Y., Rose N.R., Cihakova D. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ. Res. 2010;106:1646&#x2013;1655. doi: 10.1161/CIRCRESAHA.109.213157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.109.213157</ArticleId><ArticleId IdType="pubmed">20378858</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L., Ong S., Talor M.V., Barin J.G., Baldeviano G.C., Kass D.A., Bedja D., Zhang H., Sheikh A., Margolick J.B., et al. Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy. J. Exp. Med. 2014;211:1449&#x2013;1464. doi: 10.1084/jem.20132126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20132126</ArticleId><ArticleId IdType="pmc">PMC4076595</ArticleId><ArticleId IdType="pubmed">24935258</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers J.M., Cooper L.T., Kem D.C., Stavrakis S., Kosanke S.D., Shevach E.M., Fairweather D., Stoner J.A., Cox C.J., Cunningham M.W. Cardiac myosin-Th17 responses promote heart failure in human myocarditis. JCI Insight. 2016;1:e85851. doi: 10.1172/jci.insight.85851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.85851</ArticleId><ArticleId IdType="pmc">PMC4924810</ArticleId><ArticleId IdType="pubmed">27366791</ArticleId></ArticleIdList></Reference><Reference><Citation>Barin J.G., Baldeviano G.C., Talor M.V., Wu L., Ong S., Fairweather D., Bedja D., Stickel N.R., Fontes J.A., Cardamone A.B., et al. Fatal eosinophilic myocarditis develops in the absence of IFN-&#x3b3; and IL-17A. J. Immunol. 2013;191:4038&#x2013;4047. doi: 10.4049/jimmunol.1301282.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1301282</ArticleId><ArticleId IdType="pmc">PMC3927983</ArticleId><ArticleId IdType="pubmed">24048893</ArticleId></ArticleIdList></Reference><Reference><Citation>Afanasyeva M., Wang Y., Kaya Z., Park S., Zilliox M.J., Schofield B.H., Hill S.L., Rose N.R. Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am. J. Pathol. 2001;159:193&#x2013;203. doi: 10.1016/S0002-9440(10)61685-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)61685-9</ArticleId><ArticleId IdType="pmc">PMC1850414</ArticleId><ArticleId IdType="pubmed">11438466</ArticleId></ArticleIdList></Reference><Reference><Citation>Cihakova D., Barin J.G., Afanasyeva M., Kimura M., Fairweather D., Berg M., Talor M.V., Baldeviano G.C., Frisancho S., Gabrielson K., et al. Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. Am. J. Pathol. 2008;172:1195&#x2013;1208. doi: 10.2353/ajpath.2008.070207.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2008.070207</ArticleId><ArticleId IdType="pmc">PMC2329830</ArticleId><ArticleId IdType="pubmed">18403598</ArticleId></ArticleIdList></Reference><Reference><Citation>De Biasi S., Lo Tartaro D., Meschiari M., Gibellini L., Bellinazzi C., Borella R., Fidanza L., Mattioli M., Paolini A., Gozzi L., et al. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia. Eur. J. Immunol. 2020;50:1283&#x2013;1294. doi: 10.1002/eji.202048838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202048838</ArticleId><ArticleId IdType="pubmed">32910469</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez-Bautista J.F., Rodriguez-Nicolas A., Rosales-Castillo A., Jim&#xe9;nez P., Garrido F., Anderson P., Ruiz-Cabello F., L&#xf3;pez-Ruz M.&#xc1;. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset. Front. Immunol. 2020;11:596553. doi: 10.3389/fimmu.2020.596553.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.596553</ArticleId><ArticleId IdType="pmc">PMC7726249</ArticleId><ArticleId IdType="pubmed">33324414</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil-Etayo F.J., Su&#xe0;rez-Fern&#xe1;ndez P., Cabrera-Marante O., Arroyo D., Garcinu&#xf1;o S., Naranjo L., Pleguezuelo D.E., Allende L.M., Mancebo E., Lalueza A., et al. T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression. Front. Cell Infect. Microbiol. 2021;11:624483. doi: 10.3389/fcimb.2021.624483.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.624483</ArticleId><ArticleId IdType="pmc">PMC7952877</ArticleId><ArticleId IdType="pubmed">33718270</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong F., Dai Y., Zheng T., Cheng L., Zhao D., Wang H., Liu M., Pei H., Jin T., Yu D., et al. Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals. J. Clin. Investig. 2020;130:6588&#x2013;6599. doi: 10.1172/JCI141054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI141054</ArticleId><ArticleId IdType="pmc">PMC7685722</ArticleId><ArticleId IdType="pubmed">32841212</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura H., Francisco D., Conway M., Martinez F.D., Vercelli D., Polverino F., Billheimer D., Kraft M. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells. J. Allergy Clin. Immunol. 2020;146:80&#x2013;88.e8. doi: 10.1016/j.jaci.2020.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.05.004</ArticleId><ArticleId IdType="pmc">PMC7227558</ArticleId><ArticleId IdType="pubmed">32422146</ArticleId></ArticleIdList></Reference><Reference><Citation>Cort&#xe9;s-Vieyra R., Guti&#xe9;rrez-Castellanos S., &#xc1;lvarez-Aguilar C., Baizabal-Aguirre V.M., Nu&#xf1;ez-Anita R.E., Rocha-L&#xf3;pez A.G., G&#xf3;mez-Garc&#xed;a A. Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease. Viruses. 2021;13:1675. doi: 10.3390/v13091675.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13091675</ArticleId><ArticleId IdType="pmc">PMC8473128</ArticleId><ArticleId IdType="pubmed">34578258</ArticleId></ArticleIdList></Reference><Reference><Citation>Qeadan F., Chehade M., Tingey B., Egbert J., Dellon E.S., Peterson K.A. Patients with eosinophilic gastrointestinal disorders have lower in-hospital mortality rates related to COVID-19. J. Allergy Clin. Immunol. Pract. 2021;9:4473&#x2013;4476.e4. doi: 10.1016/j.jaip.2021.09.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2021.09.022</ArticleId><ArticleId IdType="pmc">PMC8459462</ArticleId><ArticleId IdType="pubmed">34563741</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin L.B., Weinstock L.B., Molderings G.J. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int. J. Infect. Dis. 2020;100:327&#x2013;332. doi: 10.1016/j.ijid.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezkalla S.H., Kloner R.A. Viral myocarditis: 1917-2020: From the Influenza A to the COVID-19 pandemics. Trends Cardiovasc. Med. 2021;31:163&#x2013;169. doi: 10.1016/j.tcm.2020.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2020.12.007</ArticleId><ArticleId IdType="pmc">PMC7965406</ArticleId><ArticleId IdType="pubmed">33383171</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirico D., Basso A., Sabatino J., Reffo E., Cavaliere A., Biffanti R., Cerutti A., Castaldi B., Zulian F., Da Dalt L., et al. Evolution of echocardiographic and cardiac magnetic resonance imaging abnormalities during follow-up in patients with multisystem inflammatory syndrome in children. Eur. Heart J. Cardiovasc. Imaging. 2022;23:1066&#x2013;1074. doi: 10.1093/ehjci/jeac096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeac096</ArticleId><ArticleId IdType="pmc">PMC9384104</ArticleId><ArticleId IdType="pubmed">35639926</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirico D., Castaldi B., Ciliberti P., Sabatino J., Cazzoli I., Secinaro A., Calcaterra G., Oreto L., Calabr&#xf2; M.P., Chessa M., et al. Working Group on Congenital Heart Disease of the Italian Society of Cardiology. Cardiac imaging in congenital heart disease during the coronavirus disease-2019 pandemic: Recommendations from the Working Group on Congenital Heart Disease of the Italian Society of Cardiology. J. Cardiovasc. Med. 2020;21:467&#x2013;471. doi: 10.2459/JCM.0000000000000990.</Citation><ArticleIdList><ArticleId IdType="doi">10.2459/JCM.0000000000000990</ArticleId><ArticleId IdType="pmc">PMC7314347</ArticleId><ArticleId IdType="pubmed">32487868</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirico D., Basso A., Reffo E., Cavaliere A., Castaldi B., Sabatino J., Meneghel A., Martini G., Da Dalt L., Zulian F., et al. Early Echocardiographic and Cardiac MRI Findings in Multisystem Inflammatory Syndrome in Children. J. Clin. Med. 2021;10:3360. doi: 10.3390/jcm10153360.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10153360</ArticleId><ArticleId IdType="pmc">PMC8348478</ArticleId><ArticleId IdType="pubmed">34362141</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P.P., Blet A., Smyth D., Li H. The Science Underlying COVID-19: Implications for the Cardiovascular System. Circulation. 2020;142:68&#x2013;78. doi: 10.1161/CIRCULATIONAHA.120.047549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047549</ArticleId><ArticleId IdType="pubmed">32293910</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelle S., Bucciarelli-Ducci C., Judd R.M., Kwong R.Y., Simonetti O., Plein S., Raimondi F., Weinsaft J.W., Wong T.C., Carr J. Society for Cardiovascular Magnetic Resonance (SCMR) recommended CMR protocols for scanning patients with active or convalescent phase COVID-19 infection. J. Cardiovasc. Magn. Reson. 2020;22:61. doi: 10.1186/s12968-020-00656-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-020-00656-6</ArticleId><ArticleId IdType="pmc">PMC7467754</ArticleId><ArticleId IdType="pubmed">32878639</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavazzi G., Pellegrini C., Maurelli M., Belliato M., Sciutti F., Bottazzi A., Sepe P.A., Resasco T., Camporotondo R., Bruno R., et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur. J. Heart Fail. 2020;22:911&#x2013;915. doi: 10.1002/ejhf.1828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1828</ArticleId><ArticleId IdType="pmc">PMC7262276</ArticleId><ArticleId IdType="pubmed">32275347</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P., Pittet L.F., Curtis N. How Common is Long COVID in Children and Adolescents? Pediatr. Infect. Dis. J. 2021;40:e482&#x2013;e487. doi: 10.1097/INF.0000000000003328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003328</ArticleId><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Toro A., Bozzani A., Tavazzi G., Urtis M., Giuliani L., Pizzoccheri R., Aliberti F., Fergnani V., Arbustini E. Long COVID: Long-term effects? Eur. Heart J. Suppl. 2021;23((Suppl. E)):E1&#x2013;E5. doi: 10.1093/eurheartj/suab080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/suab080</ArticleId><ArticleId IdType="pmc">PMC8503490</ArticleId><ArticleId IdType="pubmed">34650349</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudlay D.A., Shirobokov Y.a.E., Gladunova E.P., Borodulina E.A. Diagnosis of COVID-19. Methods and problems of detecting the SARS-COV-2 virus in a pandemic. Doctor. 2020;31:5&#x2013;10. (In Russian)</Citation></Reference><Reference><Citation>Stephenson T., Allin B., Nugawela M.D., Rojas N., Dalrymple E., Pinto Pereira S., Soni M., Knight M., Cheung E.Y., Heyman I., et al. Long COVID (post-COVID-19 condition) in children: A modified Delphi process. Arch. Dis. Child. 2022;107:674&#x2013;680. doi: 10.1136/archdischild-2021-323624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2021-323624</ArticleId><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="pubmed">35365499</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., De Rose C., Sinatti D., Ricchiuto A., Carfi A., Valentini P. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110:2208&#x2013;2211. doi: 10.1111/apa.15870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov I.M., Spiridonova E., Bobkova P., Gamirova A., Shikhaleva A., Andreeva M., Blyuss O., El-Taravi Y., DunnGalvin A., Comberiati P., et al. Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. Eur. Respir. J. 2021;1:2101341. doi: 10.1183/13993003.01341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkova A., Kudryavtsev I., Starshinova A., Kudlay D., Zinchenko Y., Glushkova A., Yablonskiy P., Shoenfeld Y. Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form. Pathogens. 2021;10:1408. doi: 10.3390/pathogens10111408.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10111408</ArticleId><ArticleId IdType="pmc">PMC8620929</ArticleId><ArticleId IdType="pubmed">34832564</ArticleId></ArticleIdList></Reference><Reference><Citation>Thallapureddy K., Thallapureddy K., Zerda E., Suresh N., Kamat D., Rajasekaran K., Moreira A. Long-Term Complications of COVID-19 Infection in Adolescents and Children. Curr. Pediatr. Rep. 2022;10:11&#x2013;17. doi: 10.1007/s40124-021-00260-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40124-021-00260-x</ArticleId><ArticleId IdType="pmc">PMC8803461</ArticleId><ArticleId IdType="pubmed">35127274</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewanjee S., Kandimalla R., Kalra R.S., Valupadas C., Vallamkondu J., Kolli V., Dey Ray S., Reddy A.P., Reddy P.H. COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges. Cells. 2021;10:3291. doi: 10.3390/cells10123291.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10123291</ArticleId><ArticleId IdType="pmc">PMC8699554</ArticleId><ArticleId IdType="pubmed">34943795</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann E.R., Menon M., Knight S.B., Konkel J.E., Jagger C., Shaw T.N., Krishnan S., Rattray M., Ustianowski A., Bakerly N.D., et al. Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19. Sci. Immunol. 2020;5:eabd6197. doi: 10.1126/sciimmunol.abd6197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd6197</ArticleId><ArticleId IdType="pmc">PMC7857390</ArticleId><ArticleId IdType="pubmed">32943497</ArticleId></ArticleIdList></Reference><Reference><Citation>Picchianti Diamanti A., Rosado M.M., Nicastri E., Sesti G., Pioli C., Lagan&#xe0; B. Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines. Front Immunol. 2021;30:708848. doi: 10.3389/fimmu.2021.708848.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.708848</ArticleId><ArticleId IdType="pmc">PMC8515900</ArticleId><ArticleId IdType="pubmed">34659200</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudlay D., Svistunov A., Satyshev O. COVID-19 Vaccines: An Updated Overview of Different Platforms. Bioengineering. 2022;9:714. doi: 10.3390/bioengineering9110714.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/bioengineering9110714</ArticleId><ArticleId IdType="pmc">PMC9687223</ArticleId><ArticleId IdType="pubmed">36421115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudryavtsev I.V., Arsentieva N.A., Korobova Z.R., Isakov D.V., Rubinstein A.A., Batsunov O.K., Khamitova I.V., Kuznetsova R.N., Savin T.V., Akisheva T.V., et al. Heterogenous CD8+ T Cell Maturation and &#x2018;Polarization&#x2019; in Acute and Convalescent COVID-19 Patients. Viruses. 2022;14:1906. doi: 10.3390/v14091906.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14091906</ArticleId><ArticleId IdType="pmc">PMC9504186</ArticleId><ArticleId IdType="pubmed">36146713</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eeden C., Khan L., Osman M.S., Cohen Tervaert J.W. Natural Killer Cell Dysfunction and Its Role in COVID-19. Int. J. Mol. Sci. 2020;21:6351. doi: 10.3390/ijms21176351.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21176351</ArticleId><ArticleId IdType="pmc">PMC7503862</ArticleId><ArticleId IdType="pubmed">32883007</ArticleId></ArticleIdList></Reference><Reference><Citation>Guizani I., Fourti N., Zidi W., Feki M., Allal-Elasmi M. SARS-CoV-2 and pathological matrix remodeling mediators. Inflamm. Res. 2021;70:847&#x2013;858. doi: 10.1007/s00011-021-01487-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-021-01487-6</ArticleId><ArticleId IdType="pmc">PMC8294315</ArticleId><ArticleId IdType="pubmed">34286362</ArticleId></ArticleIdList></Reference><Reference><Citation>Mylvaganam R.J., Bailey J.I., Sznajder J.I., Sala M.A. Northwestern Comprehensive COVID Center Consortium. Recovering from a pandemic: Pulmonary fibrosis after SARS-CoV-2 infection. Eur. Respir. Rev. 2021;30:210194. doi: 10.1183/16000617.0194-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0194-2021</ArticleId><ArticleId IdType="pmc">PMC8674935</ArticleId><ArticleId IdType="pubmed">34911696</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Sante G., Buonsenso D., De Rose C., Valentini P., Ria F., Sanguinetti M., Sali M. Immune profile of children with post-acute sequelae of SARS-CoV-2 infection (Long COVID) Medrxiv. 2021 doi: 10.1101/2021.05.07.21256539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.07.21256539</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatino J., Moscatelli S., Rustamova Y., Kotlar I., Avesani M., Brida M., G&#xf6;k G., Borrelli N., Marchenko O., Calvieri C. Pink International Young Academy of Cardiology. Women&#x2019;s perspective on the COVID-19 pandemic: Walking into a post-peak phase. Int. J. Cardiol. 2021;323:29&#x2013;33. doi: 10.1016/j.ijcard.2020.08.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2020.08.025</ArticleId><ArticleId IdType="pmc">PMC7423508</ArticleId><ArticleId IdType="pubmed">32800917</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>